Filing Analysis
Delisting Notice
Filed Mar 12, 2026
HIGH
Cryo-Cell International received a notice from NYSE American LLC on March 9, 2026, stating the company is not in compliance with continued listing standards under Section 1003(a). The company must submit a plan to regain compliance by April 8, 2026, to avoid potential delisting.
Red Flags
- Failure to satisfy continued listing standards.
- Risk of delisting if the compliance plan is not accepted or executed successfully.
- Potential underlying financial distress as Section 1003(a) often pertains to equity deficits or sustained losses.
Key Facts
- Notice received from NYSE American on March 9, 2026.
- Non-compliance relates to Section 1003(a) of the NYSE American Company Guide.
- Deadline to submit a compliance plan is April 8, 2026.
- Common stock continues to trade on NYSE American under the symbol 'CCEL' during the plan review period.
- Section 1003(a) typically involves requirements regarding stockholders' equity and/or net losses.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.